Skip to content
Dr. Reddy’s
-
Dr. Reddy’s halts generic semaglutide supply due to API quality issues
The setback comes at a crucial time as competition intensifies in the fast-growing market for lower-cost versions of Novo Nordisk’s blockbuster diabetes and obesity medicine.